N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide
C41H38ClF6N9O5S — CID 155924273
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide
N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide (PubChem CID 155924273) has the molecular formula C41H38ClF6N9O5S and a molecular weight of 918.32 g/mol. Its IUPAC name is N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide.
Molecular Properties
| Compound Name | N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide |
|---|---|
| PubChem CID | 155924273 |
| Molecular Formula | C41H38ClF6N9O5S |
| Molecular Weight | 918.32 g/mol |
| Exact Mass | 917.23 |
| IUPAC Name | N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide |
| SMILES | O=C(Cn1nc(C(F)F)cc1C1CC1)N[C@@H](Cc1cc(F)cc(F)c1)c1nc2cc(N3CCOCC3)ccc2c(=O)n1-c1ccc(Cl)c2c(NS(=O)(=O)C3CC3)nn(CC(F)F)c12 |
| InChI | InChI=1S/C41H38ClF6N9O5S/c42-28-7-8-32(37-36(28)39(52-56(37)19-34(45)46)53-63(60,61)26-4-5-26)57-40(50-29-17-25(3-6-27(29)41(57)59)54-9-11-62-12-10-54)31(15-21-13-23(43)16-24(44)14-21)49-35(58)20-55-33(22-1-2-22)18-30(51-55)38(47)48/h3,6-8,13-14,16-18,22,26,31,34,38H,1-2,4-5,9-12,15,19-20H2,(H,49,58)(H,52,53)/t31-/m0/s1 |
| InChIKey | BCVRBGXHUUIZQI-HKBQPEDESA-N |
| XLogP | 6.78 |
| TPSA | 158.27 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 918.32 |
| LogP ≤ 5 | 6.78 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155924273 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.